Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00175) | |||||
---|---|---|---|---|---|
Name |
Delafloxacin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Delafloxacin; 189279-58-1; ABT-492; Baxdela; WQ-3034; 1-(6-AMINO-3,5-DIFLUOROPYRIDIN-2-YL)-8-CHLORO-6-FLUORO-7-(3-HYDROXYAZETIDIN-1-YL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; Abt 492; ABT492; RX-3341; UNII-6315412YVF; 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid; 189279-58-1 (free acid; 6315412YVF; 3-Quinolinecarboxylic acid, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-; 1-(6-amino-3,5-difluoro-2-pyridyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-quinoline-3-carboxylic acid; Delafloxacin [USAN:INN]; Delafloxacinum; Quofenix; Delafloxacin (USAN); Abbott 492; DelafloxacinABT-492; C18H12ClF3N4O4; SCHEMBL294694; QCR-52; CHEMBL2105637; GTPL10799; Delafloxacin, >=98% (HPLC); DTXSID40172331; EX-A2331; ZINC3827556; CS-1478; DB11943; SB16746; WQ 3034; NCGC00390187-01; NCGC00390187-02; AC-30739; AK232294; AS-75147; HY-14814; AB0032510; Delafloxacin 100 microg/mL in Acetonitrile; FT-0697895; D09330; W-5433; RX-3341; WQ-3034; ABT492; Delafloxacin; ABT-492(Delafloxacin, RX-3341, WQ-3034); A-319492; Q5253067; 189279-58-1, 339591-82-1 (sodium salt); 1-(6-amino-3,5-difluoropyridine-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidine-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Methicillin-resistant staphylococcus infection | ICD-11: 1D01 | [1] | ||
PubChem CID | |||||
Formula |
C18H12ClF3N4O4
|
||||
Canonical SMILES |
C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O
|
||||
InChI |
1S/C18H12ClF3N4O4/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30)
|
||||
InChIKey |
DYDCPNMLZGFQTM-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=487101"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 440.8 | Topological Polar Surface Area | 120 | |
XlogP | 2.7 | Complexity | 755 | ||
Heavy Atom Count | 30 | Rotatable Bond Count | 3 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 11 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Delafloxacin 450 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Magnesium palmitostearate; Sodium bicarbonate; Water; Sodium phosphate, monobasic, unspecified form; Povidone k30; Crospovidone (12 mpa.s at 5%); Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Melinta Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [2] | |||
Delafloxacin Meglumine 300 mg For Injection | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Citric Acid Anhydrous; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Bicarbonate; Sodium Phosphate Monobasic Monohydrate
|
|||||
Dosage Form | For Injection | |||||
Company | Melinta Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Delafloxacin Meglumine 450 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Edetate Disodium (Edta); Meglumine; Sulfobutylether--Cyclodextrin
|
|||||
Dosage Form | Tablet | |||||
Company | Melinta Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.